Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.

Autor: Bengtsson NE, Hall JK, Odom GL, Phelps MP, Andrus CR, Hawkins RD, Hauschka SD, Chamberlain JR, Chamberlain JS
Jazyk: angličtina
Zdroj: Nature communications [Nat Commun] 2017 Jun 23; Vol. 8, pp. 16007. Date of Electronic Publication: 2017 Jun 23.
DOI: 10.1038/ncomms16007
Abstrakt: This corrects the article DOI: 10.1038/ncomms14454.
Databáze: MEDLINE